Involved in Scientific Research? Then you must have heard about MA-based Thermo Fisher Scientific, Inc. (TMO - Free Report) one of the leading scientific instrument manufacturers across the world. Interestingly for this acquisition-friendly company, the latest buy out of Life Technologies is expected to give birth to an unrivaled market leader serving research, Specialty Diagnostics and applied markets.

Currently, Thermo Fisher has a Zacks Rank #4 (Sell) but that could change following its impressive fourth-quarter 2016 earnings report which has just released. (You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here). We have highlighted some of the key details from the just-released announcement below:

Earnings: The current Zacks Consensus Estimate is pegged at $2.37 per share. Thermo Fisher’s adjusted earnings per share of $2.41 beat this estimate by 1.68%.

Full year adjusted earnings came in at $8.27 per share which has also surpassed the Zacks Consensus Estimate of $8.24 by 0.4%.

Thermo Fisher Scientific Inc Price and EPS Surprise

Thermo Fisher Scientific Inc Price and EPS Surprise | Thermo Fisher Scientific Inc Quote

Revenues: Thermo Fisher posted revenues of $4,953.2 billion, which has missed the Zacks Consensus Estimate for revenues of $4,985 billion.

Full year revenues came in at $18.27 billion which has also missed the Zacks Consensus Estimate of $19.56 billion.

Key Stats: Among its four business segments, Thermo Fisher delivered fourth-quarter revenues of $1.34 billion (up 10%) in Life Sciences Solutions, $1.22 billion (up 32%) in Analytical Instruments, $834 million (down 3.5%) in Specialty Diagnostics and $1.76 billion (down 3.3%) in Laboratory Products and Services respectively. However on a full-year basis all the four segments have seen increase on year-over-year basis.

Major Factors: Management seemed upbeat about its successful execution of its capital deployment strategy to create value for its shareholders. We are also encouraged about the company’s acquisition of FEI, which is expected to add leading capabilities in electron microscopy that complement Thermo Fisher’s analytical instruments portfolio. In Asia-Pacific and emerging markets, Thermo Fisher has also leveraged its industry-leading scale to drive strong growth, especially in China.

Stock Price: Following the earnings release, share prices did not show any movement in the pre-market trading session.